AVSC.jpg

Australian Veterinary Stem Cells

Leading Veterinary Stem Cell Supplier

 

Australian Veterinary Stem Cells

AVSC has been researching and developing stem cell treatments for dogs, cats and horses for a number of years at Monash University – home to Australia’s largest stem cell research group. Since 2010 AVSC has been supplying high concentration pure stem cell treatments/doses to veterinarians for specific conditions in dogs, cats and horses.  AVSC provides therapies based on the use of stem cells sourced from adipose tissue (‘ADMSC’) and Whartons Jelly (Umbilical Cord) .  ADMSC are both anti-inflammatory and multipotent – being able to regenerate/repair cartilage, tendon, ligament, and muscle tissue. 

 
Magellan Stem Cells Horses Eating.jpg
 
 

Diseases and Conditions Treated

 

The vast majority of canine clinical work has been carried out in respect to osteoarthritis and degenerative joint disorders - as well as tendon and ligament injuries etc. Apart from 'regenerative' qualities, one of the prime attributes of MSC's is their anti-inflammatory properties. Magellan provides stem cell therapies for the treatment of musculoskeletal disorders such as arthritis and degenerative joint disease in dogs and cats as well as the treatment of tendon, ligament and cartilage injuries in both dogs and horses In regard to canine (dogs) arthritis and degenerative joint disease, Magellan believes that stem cell treatments are likely to significantly improve the underlying condition, substantially reduce any pain and increase ‘mobility’.

Treatments

Stem cell treatments involve either the intra-articular, intra-lesion and/or intra-venous injection of cells depending on the nature of the disease/condition. The clinical results indicate that IA treatments generally produce a better outcome than systemic IV treatments

 
MagellanStem Cells Dog.jpg
 

Clinical Results

Results in Dogs

In regard to arthritis, veterinarians have reported that in excess of 90% of dogs treated for arthritis with an intra-articular injection of ‘pure' cultured stem cells have responded with an improvement in the condition (quality of life) of the dog treated– with  60% of dogs showing a substantial improvement (5 out of 5 on a Quality of Life score) . Veterinarians have reported that 79%  of dogs treated for arthritis with an intra-venous injection of ‘pure' cultured stem cells have reported an improvement in the condition (quality of life) of the dog.

Results in Horses

In clinical trials in excess of 75% of horses treated for tendon and ligament injuries returned to work at the ‘prior level’. Images of treated tendons have shown a rapid filling of the injured site and elegant tendon regeneration.